• Careers
  • Investors
  • News
    • Press Releases
    • Recent Media
    • Scientific Publications
  • Who We Are
    • About Nanoscope
    • Leadership
    • Management Team
    • Board of Directors
    • Visionary Advisory Committee
  • The Science
  • Our Future
    • Pipeline
    • Disease Targets
    • Clinical Trials for RP
    • Clinical Trials for Stargardt
  • For Patients
    • Hear from Patients
    • Patient & Caregiver Resources
  • Contact

Recent Posts

  • Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
  • Nanoscope Therapeutics President and Chief Scientific Officer Dr. Samarendra Mohanty to Be Featured Speaker at 2025 ISPE Annual Meeting and Expo
  • Nanoscope Therapeutics Announces Durable 3-Year Vision Improvements from REMAIN Study of MCO-010 in Retinitis Pigmentosa
  • PIE Magazine | Practical Paths to Vision Restoration, Turning Bipolar Cells into Light Catchers – Dr. Samarendra Mohanty and Dr. Stephen Tsang Talk
  • Opthalmology Times | Video Interview: AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt Disease

Recent Comments

    Archives

    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • May 2023
    • April 2023
    • March 2023
    • January 2023
    • October 2022
    • September 2022
    • July 2022
    • May 2022
    • February 2022
    • January 2022
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • October 2020
    • July 2020
    • June 2020
    • September 2018
    • October 2017

    Categories

    • Home Page
    • Nanoscope in the News
    • Nanoscope Press Release
    • Presentations
    • Publications

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    August 21, 2024 in Nanoscope in the News

    Retina Specialist: ARVO 2024 Highlights – Optogenetic therapy for retinitis pigmentosa yields BCVA improvement at one year

    Nanoscope Therapeutics 0 Like Post Comments Off on Retina Specialist: ARVO 2024 Highlights – Optogenetic therapy for retinitis pigmentosa yields BCVA improvement at one year
    Read More
    August 11, 2024 in Nanoscope in the News

    Ocular Surgery News: VIDEO: MCO-010 for retinitis pigmentosa improves vision in phase 2b/3 study

    Nanoscope Therapeutics 0 Like Post Comments Off on Ocular Surgery News: VIDEO: MCO-010 for retinitis pigmentosa improves vision in phase 2b/3 study
    Read More
    July 27, 2024 in Nanoscope in the News

    Modern Retina: ASRS 2024: RESTORE trial 100-week results presented by Dr. Michael Singer

    Nanoscope Therapeutics 0 Like Post Comments Off on Modern Retina: ASRS 2024: RESTORE trial 100-week results presented by Dr. Michael Singer
    Read More
    May 7, 2024 in Nanoscope in the News

    Ocular Surgery News: VIDEO: Optogenetic therapy shows vision improvements, safety at 12 months

    Nanoscope Therapeutics 0 Like Post Comments Off on Ocular Surgery News: VIDEO: Optogenetic therapy shows vision improvements, safety at 12 months
    Read More
    March 28, 2024 in Nanoscope in the News

    Longevity Technology: Nanoscope targets FDA approval following positive gene therapy trial results

    Nanoscope Therapeutics 0 Like Post Comments Off on Longevity Technology: Nanoscope targets FDA approval following positive gene therapy trial results
    Read More
    March 28, 2024 in Nanoscope in the News

    Pharmaceutical Technology: Nanoscope Therapeutics exhibits positive top-line Phase IIb results for MCO-010

    Nanoscope Therapeutics 0 Like Post Comments Off on Pharmaceutical Technology: Nanoscope Therapeutics exhibits positive top-line Phase IIb results for MCO-010
    Read More
    March 27, 2024 in Nanoscope in the News

    Ocular Surgery News: Gene therapy improves vision in patients with retinitis pigmentosa in phaase 2b trial

    Nanoscope Therapeutics 0 Like Post Comments Off on Ocular Surgery News: Gene therapy improves vision in patients with retinitis pigmentosa in phaase 2b trial
    Read More
    March 26, 2024 in Nanoscope in the News

    Modern Retina: Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa

    Nanoscope Therapeutics 0 Like Post Comments Off on Modern Retina: Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa
    Read More
    March 26, 2024 in Nanoscope in the News

    Pharmaphorum: Nanoscope preps filing for retinitis pigmentosa gene therapy

    Nanoscope Therapeutics 0 Like Post Comments Off on Pharmaphorum: Nanoscope preps filing for retinitis pigmentosa gene therapy
    Read More
    March 26, 2024 in Nanoscope in the News

    Fierce Biotech: Nanoscope eyes market after gene therapy restores vision for patients with retinal disease

    Nanoscope Therapeutics 0 Like Post Comments Off on Fierce Biotech: Nanoscope eyes market after gene therapy restores vision for patients with retinal disease
    Read More
    November 20, 2023 in Nanoscope in the News

    Modern Retina : https://www.modernretina.com/view/mco-010-optogenetic-gene-therapy-for-severe-vision-loss-in-stargardt-disease

    Nanoscope Therapeutics 0 Like Post Comments Off on Modern Retina : https://www.modernretina.com/view/mco-010-optogenetic-gene-therapy-for-severe-vision-loss-in-stargardt-disease
    Read More
    November 20, 2023 in Home Page, Nanoscope in the News

    The Healthcare Technology Report: The Top 25 Women Leaders in Biotechnology of 2023

    Nanoscope Therapeutics 0 Like Post Comments Off on The Healthcare Technology Report: The Top 25 Women Leaders in Biotechnology of 2023
    Read More
    November 10, 2023 in Nanoscope in the News

    Eyewire.com : Nanoscope Therapeutics Wins ‘Best of Show’ Award at AAO Eyecelerator 2023

    Nanoscope Therapeutics 0 Like Post Comments Off on Eyewire.com : Nanoscope Therapeutics Wins ‘Best of Show’ Award at AAO Eyecelerator 2023
    Read More
    October 17, 2023 in Nanoscope in the News

    Healio : VIDEO: Optogenetic Therapy Shows Promise in Advanced Retinitis Pigmentosa

    Nanoscope Therapeutics 0 Like Post Comments Off on Healio : VIDEO: Optogenetic Therapy Shows Promise in Advanced Retinitis Pigmentosa
    Read More
    October 6, 2023 in Nanoscope in the News

    Modern Retina: Euretina 2024: Safety and efficacy through week 48 in the Phase 2a STARLIGHT clinical trial

    Nanoscope Therapeutics 0 Like Post Comments Off on Modern Retina: Euretina 2024: Safety and efficacy through week 48 in the Phase 2a STARLIGHT clinical trial
    Read More
    September 18, 2023 in Nanoscope in the News

    Modern Retina : Gene Therapy: What’s to Come?

    Nanoscope Therapeutics 0 Like Post Comments Off on Modern Retina : Gene Therapy: What’s to Come?
    Read More
    August 21, 2023 in Nanoscope in the News

    Retina Today : The Latest in Gene Therapy Clinical Trials for IRD

    Nanoscope Therapeutics 0 Like Post Comments Off on Retina Today : The Latest in Gene Therapy Clinical Trials for IRD
    Read More
    August 6, 2023 in Nanoscope in the News

    Ophthalmology Times : ASRS 2023: The STARLIGHT Study

    Nanoscope Therapeutics 0 Like Post Comments Off on Ophthalmology Times : ASRS 2023: The STARLIGHT Study
    Read More
    August 6, 2023 in Nanoscope in the News

    Healio : Video: Early Data on Optogenetic Therapy in Stargardt Disease Promising

    Nanoscope Therapeutics 0 Like Post Comments Off on Healio : Video: Early Data on Optogenetic Therapy in Stargardt Disease Promising
    Read More
    May 24, 2023 in Nanoscope in the News

    Eye on the Cure Podcast Episode #46 : Aaron Osborne, MD, Chief Medical Officer and Chief Development Office of Nanoscope Therapeutics

    Nanoscope Therapeutics 0 Like Post Comments Off on Eye on the Cure Podcast Episode #46 : Aaron Osborne, MD, Chief Medical Officer and Chief Development Office of Nanoscope Therapeutics
    Read More
    Prev12345Next
    NSCOPE_nu_Logo_Horizontal_white

    FOLLOW US

    Linkedin Instagram Facebook X-twitter

    Contact Us
    Terms of Use
    Expanded Access Policy

    ©2021-2025 Nanoscope Therapeutics, Inc.

    This website uses cookies to improve your experience. By clicking "Accept", you consent to the use of ALL the cookies. However you may visit the Cookie Settings to provide a controlled consent. Cookie settings Accept
    Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled

    This is an necessary category.

    Non Necessary

    This is an non-necessary category.

    Save & Accept